Home Ingredients SoyLife® (Soy Germ Isoflavones — IFF)
Women's HealthBone Health

SoyLife® (Soy Germ Isoflavones — IFF)

Glycine max
Evidence Level
Limited
1 Clinical Trial
3 Documented Benefits
2/5 Evidence Score

SoyLife® is a soy germ isoflavone ingredient, concentrating the natural isoflavones of the soybean germ. Isoflavones are plant compounds with mild estrogen-like activity, studied for easing menopausal symptoms such as hot flashes and for maintaining bone mineral density after menopause. The human evidence is in women; effects in men are not established here.

Studied Dose Providing roughly 40 to 80 mg of isoflavones per day.
Active Compound Soy germ extract standardized to isoflavones (genistein, daidzein, and glycitein) in their natural ratio.

Benefits

Menopausal support

Soy isoflavones are studied for easing menopausal symptoms such as hot flashes by gently engaging estrogen receptors during the hormonal transition.

Supported by Trial 1

Bone health

By supporting estrogen-receptor signaling in bone, isoflavones are researched for helping maintain bone mineral density after menopause.

Supported by Trial 1

Mild estrogen-like activity

Isoflavones have mild estrogen-like activity that differs by tissue. The human evidence is strongest for easing menopausal hot flashes in women; the only trial of this ingredient in men tested a prostate condition and was largely null, so a broader hormonal balancing effect is not established.

Supported by Trial 1

Mechanism of action

1

Selective estrogen-receptor activity

Isoflavones bind estrogen receptors weakly and selectively, acting as mild agonists or antagonists depending on the tissue and hormonal environment.

2

Antioxidant phytoestrogens

Genistein and daidzein also have antioxidant activity that supports cardiovascular and hormonal health.

Clinical trials

1
Soy Isoflavones for Benign Prostatic Hyperplasia in Men (largely null pilot trial)
PubMed

Study of isoflavones in the management of watchful-waiting benign prostatic conditions. (Wong et al. 2012, Journal of Alternative and Complementary Medicine)

Men with benign prostate enlargement.

This was a 176 man pilot trial of 40 mg/day soy isoflavones in benign prostatic hyperplasia, a men's urinary condition. Both the isoflavone and placebo groups improved over 12 months, and between group differences were marginal (peak urine flow p=0.055, not significant). The trial did not measure menopausal symptoms or bone density, so it does not support the Women's Health or Bone Health uses on this page.

Side effects and drug interactions

Common Potential side effects

Generally well-tolerated — soy isoflavones are well tolerated.
Mild digestive upset is occasionally reported.
Those with soy allergy should avoid it.

Important Drug interactions

Hormone therapy and tamoxifen — isoflavones have mild estrogenic activity; consult your doctor.
Thyroid medication — soy may affect absorption; separate dosing.
Hormone-sensitive conditions — discuss with your physician before use.

More Women's Health Ingredients

Women's Health
Chasteberry / Vitex (Vitex agnus-castus)
Chasteberry (Vitex agnus-castus) fruit extract is among the most clinically studied botani…
Women's Health
P-5-P (Pyridoxal-5-Phosphate / Active B6)
P-5-P (pyridoxal-5-phosphate, PLP) is the coenzyme form of vitamin B6 that cells use in mo…
Women's Health
Libifem® (Fenugreek for Female Libido)
Libifem® is a standardized fenugreek seed extract (the Fenuside™ furostanol saponin fracti…
Women's Health
Fennel (Foeniculum vulgare)
Fennel seed is an aromatic culinary and medicinal herb used mainly for digestive comfort,…

Frequently asked questions about SoyLife® (Soy Germ Isoflavones — IFF)

What is SoyLife?

SoyLife® is a soy germ isoflavone ingredient, concentrating the natural isoflavones of the soybean germ. Isoflavones are plant compounds with mild estrogen-like activity, studied for easing menopausal symptoms such as hot flashes and for maintaining bone mineral density after menopause.

What is SoyLife used for?

SoyLife is researched primarily for Women's Health and Bone Health. Soy isoflavones are studied for easing menopausal symptoms such as hot flashes by gently engaging estrogen receptors during the hormonal transition.

What is the recommended dosage of SoyLife?

The clinically studied dose is Providing roughly 40 to 80 mg of isoflavones per day. Always follow the product label and check with a healthcare provider for personal advice.

Is SoyLife safe, and does it have side effects?

For most healthy adults, SoyLife is well tolerated at studied doses. Reported effects can include: Generally well-tolerated — soy isoflavones are well tolerated. Mild digestive upset is occasionally reported. It may also interact with some medications. SoyLife is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does SoyLife interact with any medications?

Possible interactions include: Hormone therapy and tamoxifen — isoflavones have mild estrogenic activity; consult your doctor. Thyroid medication — soy may affect absorption; separate dosing. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for SoyLife?

NutraSmarts rates the evidence for SoyLife as Limited (2 out of 5). It is backed by 1 clinical trial and 3 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(3 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Wong WC, Wong EL, Li H, et al. Isoflavones in treating watchful waiting benign prostate hyperplasia: a double-blind, randomized, controlled trial. J Altern Complement Med. 2012;18(1):54-60..PubMedUsed to support: Randomized, double-blind, placebo-controlled pilot trial of 40 mg/day soy isoflavones (Soylife 40) in 176 men with benign prostatic hyperplasia. Both the isoflavone and placebo groups improved over 12 months, and between group differences were marginal (peak urine flow p=0.055, not significant), so the trial was largely null. It measured urinary outcomes in men, not menopausal or bone outcomes.
  2. Franco OH, Chowdhury R, Troup J, et al. Use of Plant-Based Therapies and Menopausal Symptoms: A Systematic Review and Meta-analysis. JAMA. 2016;315(23):2554-2563. doi: 10.1001/jama.2016.8012.PubMedUsed to support: Meta-analysis of 62 randomized trials (6,653 women). Soy isoflavone supplementation was associated with a modest reduction in daily hot flashes (pooled mean difference about -0.79 per day for soy isoflavones specifically) and in vaginal dryness, but not in night sweats. Evidence quality was heterogeneous and 74% of the included trials were at high risk of bias.
  3. Barańska A, Kanadys W, Bogdan M, et al. The Role of Soy Isoflavones in the Prevention of Bone Loss in Postmenopausal Women: A Systematic Review with Meta-Analysis of Randomized Controlled Trials. J Clin Med. 2022;11(16):4676. doi: 10.3390/jcm11164676.PubMedUsed to support: Meta-analysis of 18 randomized trials. Isoflavone intake (median about 106 mg/day, range 40 to 300 mg, for 6 to 24 months) produced small but statistically significant gains in bone mineral density at the lumbar spine (+1.63%), femoral neck (+1.87%), and total hip (+0.39%) in menopausal women. Effects varied by dose, duration, and population (Asian versus Caucasian).